Eudaimonia Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Eudaimonia Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	-$32K	–	679
2021 Q1	$32K	Hold	200	–	–	0.01%	784
2020 Q4	$34K	Hold	200	–	–	0.01%	715
2020 Q3	$31K	Hold	200	–	–	0.01%	676
2020 Q2	$34K	Hold	200	–	–	0.01%	586
2020 Q1	$26K	Hold	200	–	–	0.01%	601
2019 Q4	$30K	Buy	+200	New	+$27.5K	0.01%	602

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Eudaimonia Partners's FBT Position: Q2 2021 in Review

Eudaimonia Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2021, closing a stake of 200 shares — an estimated $32K sold.

Eudaimonia Partners first reported a position in FBT in Q4 2019 and held it in 6 quarters. The position peaked at $34K in Q4 2020. 233 funds tracked by Wall St. Rank hold FBT as of Q2 2021.

Eudaimonia Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2021 after selling out during the quarter.
Eudaimonia Partners sold 200 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2021, an estimated $32K.
Eudaimonia Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2019 and held it in 6 quarters.
Eudaimonia Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $34K in Q4 2020.
233 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.